The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. - Wikidata - wikimedia - TriplyDB

The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.

The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.

http://www.wikidata.org/entity/Q35090215

about

Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond Energy metabolism in the liver Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease Fructose consumption: recent results and their potential implications Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.Fructose: it's "alcohol without the buzz".The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data Fructose-Rich Diet Affects Mitochondrial DNA Damage and Repair in Rats.High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.Diacylglycerol-mediated insulin resistance.Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.High dietary fructose intake: Sweet or bitter life?Toward a unifying hypothesis of metabolic syndrome.Liver-specific PGC-1beta deficiency leads to impaired mitochondrial function and lipogenic response to fasting-refeeding.PGC-1 coactivators in the control of energy metabolism.Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism Per capita sugar consumption and prevalence of diabetes mellitus--global and regional associations.The impact of fructose on renal function and blood pressure.Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats SirT1 regulates adipose tissue inflammation.A Grape Seed Procyanidin Extract Ameliorates Fructose-Induced Hypertriglyceridemia in Rats via Enhanced Fecal Bile Acid and Cholesterol Excretion and Inhibition of Hepatic Lipogenesis.The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway.The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes.Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats Nuclear receptors reverse McGarry's vicious cycle to insulin resistance.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose

P2860

Q24594113-776E929F-6BFA-49C4-9429-670C1F484617 Q26752583-2AD4AEB5-B7C8-4CD3-BB0F-A5C505E8399A Q26798161-3D1931CB-67A0-45D7-9E60-9B89B936E8DF Q26801099-63EBC83B-717B-4049-9DC6-903365160D10 Q26991952-B93DAC6E-6896-4446-B08F-F4ED076D80D8 Q26996576-6D49EAB5-592A-43AC-BACE-CA73CF3803BA Q26996783-F5078C4B-4664-429E-B5E9-EFB2E799ACB3 Q27007233-897F6F22-73A0-481C-8A5A-3904E301C25E Q27016052-6BDA0B55-E91C-4DF8-AC1C-36394089FEFC Q27968226-072358BF-FBFB-4EC6-AD63-FAFECD3C274B Q28390197-4A409226-3B95-4B47-B8B3-DE7323577CBA Q30249128-0167F330-BC12-43F0-AA7D-A172B37D8312 Q30301218-7A26E537-A92B-45D3-A0A3-5E9EB7C20E9B Q30428239-0370BA29-C3D6-44C1-9361-A0D3F8DCFB5D Q30596703-E8A45BC6-C0D2-451F-B0D8-0CD32F3D004B Q33616550-CCCA70C8-C28A-498B-896F-A8F2195D6E4C Q33616618-E0394BD3-1391-4951-A0A3-5B659A6AB742 Q33616976-FEF54948-47A8-4F53-8955-DF8D4CDFD49C Q33789323-5D5A0ACE-7735-4F83-8564-846BB25C905E Q34109119-88B773FC-1092-402C-9F04-A2CF053973BA Q34166238-E0DE73AD-068B-43E2-A64D-65089DA4EBD6 Q34210101-7C3A7DAD-2361-4138-A504-D21D17E9D63B Q34255878-FB267498-E38D-4B5B-BD25-6D449B77A490 Q34534313-B2BB7C33-C495-4E8D-A979-B524992A1206 Q34712077-3A0F11D6-EDB8-4D92-BDCD-61885108E850 Q34776347-425CAE34-2BC2-4AD5-A960-184E2CA38B0E Q35098798-A729782E-8E79-492F-9171-6F4EDAC4F51C Q35116270-ACD4AD0F-022F-432D-8290-0F910CC0E834 Q35559692-70458A78-3BDC-4719-A520-579CCE106E16 Q35561122-CA3306FC-5314-4EA9-86FD-A4FAE235AFDD Q35803459-9093DF5E-B089-4FBD-BFE7-B9FCEBCDE816 Q35811523-14248900-71A3-452C-B513-8849D33F10BA Q35870803-552EA272-2262-47BA-9406-8AF6F1F69AC9 Q35964800-E98D6F91-A1E6-4E98-97A0-0E29B4FCB248 Q36411221-4B235E4F-A815-49CE-A18A-A410EE0096BD Q36430696-F333BC52-D802-4E2B-BD27-34954FF25DD9 Q36507547-59B97EA4-9094-44F0-B151-1E58A61F343A Q36684364-8618DBFC-A022-40F2-AA7A-F70E1C84332F Q36732028-97941EC3-7A47-4816-BEC5-7508C72293A6 Q36800168-8C57C7A4-8F18-4486-8E41-8BB285C79AC5

P2860

The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.

http://www.wikidata.org/entity/Q35090215

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The role of peroxisome prolife ...... se-induced insulin resistance.

@ast

The role of peroxisome prolife ...... se-induced insulin resistance.

@en

type

label

The role of peroxisome prolife ...... se-induced insulin resistance.

@ast

The role of peroxisome prolife ...... se-induced insulin resistance.

@en

prefLabel

The role of peroxisome prolife ...... se-induced insulin resistance.

@ast

The role of peroxisome prolife ...... se-induced insulin resistance.

@en

P1433

Q35090215-73C0AC18-8B29-40EB-AC7E-FCE63EC6675D

P1476

Q35090215-C8F78FA3-960D-4203-8981-CBB0D80BF000

P2093

Q35090215-031B30C0-BD6F-448A-BAB3-40EE83ACC544

Q35090215-22A6CBA6-4D05-4325-9230-25068A2202E5

Q35090215-26106A04-9D95-4B4E-82FB-BCD53CC97FC4

Q35090215-3203A44F-5033-48D5-9247-F336905F8690

Q35090215-3E971453-0841-41BD-9E85-CAFFCA95FF2B

Q35090215-642B978C-FC0B-49D8-9BC5-B5CDD35FDEF0

Q35090215-6F932C16-3FF2-4D3C-B0D5-CCB36E4E3079

Q35090215-70925896-16AC-4FD3-A7C7-B2EDC12842C0

Q35090215-7C0DFC3B-834B-4D69-B4E3-F037A1C6BFFB

Q35090215-7FE66AE0-CBC0-45CF-A361-3FBB54106385

P2860

Q35090215-04027AA7-4FDB-4C1D-98D0-E16F5EE94C21

Q35090215-18DD1C06-B19C-4E8A-B57C-A4A230F554D7

Q35090215-1CF8062A-22D2-452C-8755-69B269A9EAC0

Q35090215-269B10C8-8DF2-4322-88F6-B34732065891

Q35090215-3E7B542A-4CAE-4FC2-BAA9-7A93E7254075

Q35090215-42DAF1AC-59B4-409E-B9B8-3595C6E38E6F

Q35090215-49BE3E13-FDA4-4DF2-99CB-4A82584F83F7

Q35090215-4C3ABE8E-5D45-4EF7-BF79-02498A4BACF4

Q35090215-5143A521-4B73-4E98-B2B5-8346070DEEE7

Q35090215-522C4562-3B1E-40F9-9224-0E53FF0DB9C5

P304

Q35090215-FE6DDFA0-78DF-4118-9D92-BBC885DEBE16

P31

Q35090215-708E09DC-3642-4EC8-8F77-C0F58035C254

P356

Q35090215-9992CB12-9376-4C98-ABBD-DB447CC64F72

P433

Q35090215-2B13892F-6E51-4F33-B856-7262AC879E4F

P478

Q35090215-34453114-59BE-4B90-945A-4DD53D95918C

P50

Q35090215-1E358FA1-84FC-41C9-9A03-85F579CA0F91

Q35090215-600932AC-027D-470D-A473-591B544B3B5B

Q35090215-60612258-F07A-42F0-8E1B-BC98EDC51B10

Q35090215-8F5B1F70-A89B-4F76-A373-0C11BF6BECE6

P577

Q35090215-13FFD590-721D-4BAF-8E7A-9B5B1C66E364

P5875

Q35090215-C246073A-DD2C-4891-82B6-DD8EE78753BE

P698

Q35090215-5FBCBF1E-4ECB-489A-AF0C-84059C9E1387

P921

Q35090215-0D7F083D-A803-4B31-B0BD-E68E69712571

P932

Q35090215-5B5B5464-A7F1-48C6-888E-230535A8984C

P356

J.CMET.2009.01.011

P1433

Cell Metabolism

P1476

The role of peroxisome prolife ...... ose-induced insulin resistance

@en

P2093

Brett P Monia

http://www.w3.org/2001/XMLSchema#string

Derek M Erion

http://www.w3.org/2001/XMLSchema#string

Dirk Weismann

http://www.w3.org/2001/XMLSchema#string

Dongyan Zhang

http://www.w3.org/2001/XMLSchema#string

James Cresswell

http://www.w3.org/2001/XMLSchema#string

Jianying Dong

http://www.w3.org/2001/XMLSchema#string

Romana Stark

http://www.w3.org/2001/XMLSchema#string

Sanjay Bhanot

http://www.w3.org/2001/XMLSchema#string

Shin Yonemitsu

http://www.w3.org/2001/XMLSchema#string

Susan F Murray

http://www.w3.org/2001/XMLSchema#string

P2860

Fructose, insulin resistance, and metabolic dyslipidemia

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

A new mathematical model for relative quantification in real-time RT-PCR

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor

Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance

PGC-1beta in the regulation of hepatic glucose and energy metabolism

Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

P304

252-264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2009.01.011

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Michael Löffler

Michael J. Jurczak

Gerald I. Shulman

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24170962

http://www.w3.org/2001/XMLSchema#string

P698

19254570

http://www.w3.org/2001/XMLSchema#string

P921

P932

3131094

http://www.w3.org/2001/XMLSchema#string